Applied Therapeutics to Present at the UBS Global Healthcare Conference
May 19, 2022 07:00 ET
|
Applied Therapeutics
NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics Reports First Quarter 2022 Financial Results
May 12, 2022 06:59 ET
|
Applied Therapeutics
NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve Society
May 05, 2022 07:30 ET
|
Applied Therapeutics
Sorbitol correlates with disease severity in patients with SORD DeficiencyAT-007 treatment substantially reduced sorbitol levels in a pilot study in SORD DeficiencySorbitol elevation results in...
Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders
April 04, 2022 07:30 ET
|
Applied Therapeutics
NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics
March 16, 2022 07:30 ET
|
Applied Therapeutics
NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results
March 10, 2022 07:30 ET
|
Applied Therapeutics
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
March 01, 2022 07:00 ET
|
Applied Therapeutics
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics Supports 15th Annual Rare Disease Day
February 28, 2022 07:30 ET
|
Applied Therapeutics
NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022 07:00 ET
|
Applied Therapeutics
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Applied Therapeutics Provides Regulatory Update on Galactosemia Program
January 03, 2022 07:00 ET
|
Applied Therapeutics
NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...